Literature DB >> 18426439

Effects of cigarette smoking on heart rate variability and plasma N-terminal pro-B-type natriuretic peptide in healthy subjects: is there the relationship between both markers?

Omer Alyan1, Fehmi Kacmaz, Ozcan Ozdemir, Orhan Maden, Serkan Topaloglu, Cemal Ozbakir, Fatma Metin, Aziz Karadede, Erdogan Ilkay.   

Abstract

BACKGROUND: Cigarette smoking increased the risk of acute cardiac events related with endothelial dysfunction and increased sympathetic activity. Impaired autonomic nervous activity is recognized as a considerable symptom of cardiac dysfunction and is strongly associated with increased risk overall mortality.
METHODS: A total of 75 healthy habitual smokers (40 female, 35 male, mean age 36.5 +/- 8.5 years), and 73 non-smokers subjects (45 female, 28 male, mean age 34.6 +/- 7.2 years) were studied. LF and LF/HF ratio were significantly higher in smokers than in non-smokers. On the contrary, SDNN, SDANN, RMSSD, and HF values were lower in smokers compared to those in non-smokers. Not the duration of smoking but the number of cigarettes smoked per day was correlated with the HRV parameters and NT-pro BNP. Furthermore, the average levels of NT-pro BNP were found to be positively correlated with LF, LF/HF and inversely correlated with SDNN, SDANN, RMSSD and HF.
RESULTS: As a result, smoking impaires sympathovagal balance and decreases the heart rate variability in healthy subjects. And even a one cigarette smoking leads to overt sympathetic excitation. Furthermore, smoking results in an increase in NT-proBNP levels and the changes in adrenergic nervous system and NT-proBNP levels are well correlated.
CONCLUSION: These findings could contribute to the higher rate of cardiovascular events in smokers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18426439      PMCID: PMC6932583          DOI: 10.1111/j.1542-474X.2008.00213.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  39 in total

1.  Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations.

Authors:  Bjoern A Groenning; Jens C Nilsson; Lars Sondergaard; Frants Pedersen; Jürgen Trawinski; Matthias Baumann; Henrik B W Larsson; Per R Hildebrandt
Journal:  Am Heart J       Date:  2002-05       Impact factor: 4.749

2.  Acute effects of smoking on diastolic function in healthy participants: studies by conventional doppler echocardiography and doppler tissue imaging.

Authors:  Mahbubul Alam; Bassem A Samad; Johan Wardell; Eva Andersson; Christer Höglund; Rolf Nordlander
Journal:  J Am Soc Echocardiogr       Date:  2002-10       Impact factor: 5.251

3.  Persistent blood pressure increase induced by heavy smoking.

Authors:  A Groppelli; D M Giorgi; S Omboni; G Parati; G Mancia
Journal:  J Hypertens       Date:  1992-05       Impact factor: 4.844

Review 4.  Cardiovascular neural regulation explored in the frequency domain.

Authors:  A Malliani; M Pagani; F Lombardi; S Cerutti
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

5.  Smoking and cardiovascular disease. Effect of nicotine on the serum epinephrine and corticoids.

Authors:  P Hill; E L Wynder
Journal:  Am Heart J       Date:  1974-04       Impact factor: 4.749

6.  Mechanisms responsible for sympathetic activation by cigarette smoking in humans.

Authors:  G Grassi; G Seravalle; D A Calhoun; G B Bolla; C Giannattasio; M Marabini; A Del Bo; G Mancia
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

7.  Differences in the immediate effects of smoking on left ventricular diastolic function between healthy volunteers and patients with type 2 diabetes mellitus.

Authors:  Hyung-Kwan Kim; Jang-Whan Bae; Joong-Wha Chung; Young Min Cho; Yong-Jin Kim; Dae-Won Sohn; Young-Bae Park
Journal:  J Am Soc Echocardiogr       Date:  2005-04       Impact factor: 5.251

8.  Cigarette smoking and heart rate variability: dynamic influence of parasympathetic and sympathetic maneuvers.

Authors:  Irfan Barutcu; Ali Metin Esen; Dayimi Kaya; Muhsin Turkmen; Osman Karakaya; Mehmet Melek; Ozlem Batukan Esen; Yelda Basaran
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-07       Impact factor: 1.468

9.  Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.

Authors:  D S Celermajer; K E Sorensen; D Georgakopoulos; C Bull; O Thomas; J Robinson; J E Deanfield
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

10.  Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both.

Authors:  D J Moliterno; J E Willard; R A Lange; B H Negus; J D Boehrer; D B Glamann; C Landau; J D Rossen; M D Winniford; L D Hillis
Journal:  N Engl J Med       Date:  1994-02-17       Impact factor: 91.245

View more
  12 in total

1.  Influence of heavy cigarette smoking on heart rate variability and heart rate turbulence parameters.

Authors:  Goksel Cagirci; Serkan Cay; Ozlem Karakurt; Neslihan Eryasar; Veli Kaya; Aytun Canga; Asuman Bicer Yesilay; Harun Kilic; Serkan Topaloglu; Dursun Aras; Ahmet Duran Demir; Ramazan Akdemir
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-10       Impact factor: 1.468

2.  The Association of Cigarette Smoking With High-Frequency Heart Rate Variability: An Ecological Momentary Assessment Study.

Authors:  Fernando Bodin; Kathleen M McIntyre; Joseph E Schwartz; Paula S McKinley; Caitlyn Cardetti; Peter A Shapiro; Ethan Gorenstein; Richard P Sloan
Journal:  Psychosom Med       Date:  2017 Nov/Dec       Impact factor: 4.312

3.  Linking Daily Stress Processes and Laboratory-Based Heart Rate Variability in a National Sample of Midlife and Older Adults.

Authors:  Nancy L Sin; Richard P Sloan; Paula S McKinley; David M Almeida
Journal:  Psychosom Med       Date:  2016-06       Impact factor: 4.312

4.  Vagally-mediated heart rate variability and indices of well-being: Results of a nationally representative study.

Authors:  Richard P Sloan; Emilie Schwarz; Paula S McKinley; Maxine Weinstein; Gayle Love; Carol Ryff; Daniel Mroczek; Tse-Hwei Choo; Seonjoo Lee; Teresa Seeman
Journal:  Health Psychol       Date:  2016-08-29       Impact factor: 4.267

Review 5.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

6.  Pharmacokinetic-pharmacodynamic modelling of acute N-terminal pro B-type natriuretic peptide after doxorubicin infusion in breast cancer.

Authors:  Shuang Liang; Richard C Brundage; Pamala A Jacobson; Anne Blaes; Mark N Kirstein
Journal:  Br J Clin Pharmacol       Date:  2016-06-03       Impact factor: 4.335

7.  Effects of posture and acute sleep deprivation on heart rate variability.

Authors:  Ki Chang Nam; Min Kyung Kwon; Deok Won Kim
Journal:  Yonsei Med J       Date:  2011-07       Impact factor: 2.759

8.  Are smoking and passive smoking related with heart rate variability in male adolescents?

Authors:  Renata Melo Gondim; Breno Quintella Farah; Carolina da Franca Bandeira Ferreira Santos; Raphael Mendes Ritti-Dias
Journal:  Einstein (Sao Paulo)       Date:  2015-03-03

9.  High N-terminal pro-B-type natriuretic peptide levels are associated with reduced heart rate variability in acute myocardial infarction.

Authors:  Luc Lorgis; Daniel Moreau; Laurent Mock; Bernadette Daumas; Daniel Potard; Claude Touzery; Yves Cottin; Marianne Zeller
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

10.  Heart rate variability is related to self-reported physical activity in a healthy adolescent population.

Authors:  Eva Henje Blom; Erik M G Olsson; Eva Serlachius; Mats Ericson; Martin Ingvar
Journal:  Eur J Appl Physiol       Date:  2009-05-29       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.